Efficacy Response News Today

Researchers investigated whether higher endogenous testosterone levels increase atrial fibrillation (AF) risk among healthy older males.

Men with prediabetes and diabetes have a high prevalence of hypogonadism. A trial tested testosterone replacement therapy’s efficacy in preventing progression from prediabetes to diabetes in men.

Testosterone replacement therapy for hypogonadism was associated with improved mood and energy among participants with depressive symptoms.

Testosterone replacement therapy for hypogonadism was associated with improved mood and energy among participants with depressive symptoms.

For men with hypogonadism and low prostate cancer risk, TRT didn't increase the risk for prostate adverse events, said a new analysis likely to inform decision-making.

Findings from a large randomized trial could facilitate decision-making regarding treatment for hypogonadism. Testosterone replacement therapy is associated with low risks of prostate cancer and other adverse prostate issues in most men.

Findings from a large randomized trial could facilitate decision-making regarding treatment for hypogonadism. Testosterone replacement therapy is associated with low risks of prostate cancer and other adverse prostate issues in most men.

Effect of Psychological and Medication Therapies for Insomnia on Daytime Functions: A Randomized Clinical Trial 1. Patients randomized to receive both behavioural therapy (BT) and zolpidem were found to have a significant improvement in anxiety symptoms, fatigue, functional impairments, and mental health scores. 2. The addition of a second-stage treatment offered further improvements in daytime functions. Evidence

Nearly 15% of older men with hypogonadism experience anemia. TRAVERSE is the first trial to report the effects of testosterone replacement therapy (TRT) on anemia incidence in hypogonal men.

Racial differences in low-value care among older adult Medicare patients in US health systems: a retrospective cohort study 1. In this retrospective cohort study of Medicaid patients in the United States, Black participants were more likely than White participants to receive low-value diagnostic tests, while White participants were more likely than Black participants to receive